ResearcherNational Cancer Centre SingaporeNo recent work listed
Matthew Chau Hsien Ng
Matched on ORCID iD 0000-0003-3170-4126; OpenAlex author ID A5025416634.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 1 (first author 1, last author 0)
- Pancreatic cancer trials
- 1 (principal investigator on 1)
- Pancreatic cancer grants
- 0
- Collaborators
- 2
2013: 1 trial · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper
Papers 1
Trials 1
- OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma Principal investigator NCT02368860↗
Closest collaborators
The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Balram Chowbay · 1 shared paper, 2022
- David Wai-Meng Tai · 1 shared paper, 2022
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.